• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Biomed Sci . Coronavirus vaccine development: from SARS and MERS to COVID-19

tetano

Editor, Senior Moderator
J Biomed Sci


. 2020 Dec 20;27(1):104.
doi: 10.1186/s12929-020-00695-2.
Coronavirus vaccine development: from SARS and MERS to COVID-19


Yen-Der Li[SUP] 1 [/SUP], Wei-Yu Chi[SUP] 2 [/SUP], Jun-Han Su[SUP] 1 [/SUP], Louise Ferrall[SUP] 2 [/SUP], Chien-Fu Hung[SUP] 2 [/SUP], T-C Wu[SUP] 3 4 [/SUP]



Affiliations
Free article

Abstract

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a new type of coronavirus that causes the Coronavirus Disease 2019 (COVID-19), which has been the most challenging pandemic in this century. Considering its high mortality and rapid spread, an effective vaccine is urgently needed to control this pandemic. As a result, the academia, industry, and government sectors are working tightly together to develop and test a variety of vaccines at an unprecedented pace. In this review, we outline the essential coronavirus biological characteristics that are important for vaccine design. In addition, we summarize key takeaways from previous vaccination studies of Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV) and Middle East Respiratory Syndrome Coronavirus (MERS-CoV), highlighting the pros and cons of each immunization strategy. Finally, based on these prior vaccination experiences, we discuss recent progress and potential challenges of COVID-19 vaccine development.

Keywords: Coronaviruses; SARS-CoV-2; Vaccine; Vaccine development
 
Back
Top Bottom